Clinical trial

Depocyt® With Sorafenib in Neoplastic Meningitis

NCT00964743

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2009-08-01

PhaseNA

Study timeline

Study start (unknown)2009-08-01Date precision: month

Registry last updated2013-09-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Neoplastic Meningitisunresolved

Interventions

DepoCytDRUG

SorafenibDRUG · verified · RxNorm: sorafenib

Sponsors & collaborators

H. Lee Moffitt Cancer Center and Research Institutelead sponsor

Bayercollaborator

Mapped research locations

TampaFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00964743 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.